Диссертация (1174340), страница 20
Текст из файла (страница 20)
Lo, M.S. Tein,T.K. Lau [et al.] // Am. J. Hum. Genet. - 1998. - T. 62 - №4 – с.768-775.52.Chan K.C.A. Size distributions of maternal and fetal DNA in maternalplasma. / K. C. A. Chan, J. Zhang, A. B. Y. Hui [et al.] // Clin. Chem. - 2004. - Т.50 - № 1- с.88-92.53.Lo Y.M. Rapid clearance of fetal DNA from maternal plasma. /Y.M. Lo, J.
Zhang, T.N. Leung [et al.] // Am. J. Hum. Genet. - 1999. - T.64 - №1– с.218–224.54.Mandel P. Les acides nucleiques du plasma sanguin chez l’homme. /P. Mandel, P. Metais // C. R. Acad. Sci. Paris - 1948.- № 142 – с.241-243.55.Tan E.M. Deoxybonucleic acid (DNA) and antibodies to DNA in theserum of patients with systemic lupus erythematosus. / E.M.
Tan, P.H. Schur, R.I.Carr, H.G. Kunkel // J. Clin. Invest. - 1966. – T.45 -№11 – с.1732-40.56.Козлов В.А. Свободная внеклеточная ДНК в норме и припатологии. / В.А. Козлов // Медицинская иммунология - 2013. - T. 15 - № 5с.399-412.57.Peters D.L. Origin, translocation and destination of extracellularoccurring DNA - a new paradigm in genetic behaviour. D.L. Peters, P.J. Pretorius //Clin. Chim. Acta. – 2011. T.412 - №11 – с.806-11.58.Choi J.J. The role of macrophages in the in vitro generation ofextracellular DNA from apoptotic and necrotic cells. / J.J.
Choi, C.F. Reich, D.S.Pisetsky // Immunology - 2005. - T. 115 - № 1 – с.55-62.59.Li C.N. Cell-free DNA is released from tumor cells upon cell death: astudy of tissue cultures of tumor cell lines. / C.N. Li, H.L. Hsu, T.L. Wu [et al.] //J. Clin. Lab. Anal. - 2003. – T.17 - № 4 – с.103-107.60.Jahr S. DNA fragments in the blood plasma of cancer patients:quantitations and evidence for their origin from apoptotic and necrotic cells. /126S.
Jahr, H. Hentze, S. Englisch [et al.] // Cancer. Res. - 2001. - T.15 - №61 –с.1659-1665.61.Stroun M. About the possible origin and mechanism of circulatingDNA apoptosis and active DNA release. / M. Stroun, J. Lyautey, C. Lederrey [etal.] // Clin. Chim. Acta. - 2001. – T. 313 - №№ 1-2 - с.139-142.62.Suzuki N. Characterization of circulating DNA in healthy humanplasma. / N.
Suzuki, A. Kamataki, J. Yamaki, Y. Homma // Clin. Chim. Acta 2008. - T. 387. - №№ 1-2 - с.55-58.63.Gahan P.B. Circulating nucleic acids in plasma and serum. / P.B.Gahan, R. Swaminathan // Recent developments. Ann. N. Y. Acad. Sci.- 2008. –№ 1137 – с.1-6.64.Favaloro B. Role of apoptosis in disease.
/ B. Favaloro, N. Allocati,V. Graziano,, C. Di Ilio, V. De Laurenzi // Aging (Albany N.Y.) – 2012. – T.4 - №5 – с.330-349.65.Nagata S. Autoimmune diseases caused by defects in clearing deadcells and nuclei expelled from erythroid precursors. / S. Nagata // Immunol. Rev –2007. - № 220 – с.237-250.66.Choi J.J.
The role of macrophages in the in vitro generation ofextracellular DNA from apoptotic and necrotic cells. / J.J. Choi, C.F. Reich 3rd,D.S. Pisetsky // Immunology – 2005. – T. 115 - № 1 – с.55-62.67.Pisetsky D.S. The origin of extracellular DNA during the clearance ofdead and dying cells. / D.S. Pisetsky, A.M.
Fairhurst //Autoimmunity – 2007. T.40 - № 4 – с.281-284.68.Lo Y.M. Circulating nucleic acids in plasma and serum: an overview. /Y.M. Lo // Ann N Y Acad Sci. - 2001. - № 945- P. 1-7.69.Alberry M. Free fetal DNA in maternal plasma in anembryonicpregnancies: confirmation that the origin is the trophoblast. / M. Alberry,D. Maddocks, M.
Jones [et al.] // Prenat. Diagn. – 2007. – Т. 27 – № 5– с.415–8.70.Пантюх К.С.Неинвазивнаяпренатальнаядиагностикаанеуплоидий плода, основанная на секвенировании внеклеточной ДНК крови127беременной женщины. / К.С. Пантюх К.С., Е.С. Шубина // Акушерство игинекология - 2015. - № 8- с.5-11.71.Breitbach S. Circulating cell-free DNA: an up-coming molecularmarker in exercise physiology. / S. Breitbach, S. Tug, P. Simon // Sports. Med. 2012. T. 42 - №7- с.565-86.72.Lo Y.M.
Maternal plasma DNA sequencing reveals the genome-widegenetic and mutational profile of the fetus. / Y.M. Lo, K.C. Chan, H. Sun [et al.] //Sci. Transl. Med. - 2010.- T.61 - №2 - 61ra91 – с.1-13.73.Ashoor G. Fetal fraction in maternal plasma cell-free DNA at 11-13weeks’ gestation: effect of maternal and fetal factors. / G. Ashoor, L. Poon,A. Syngelaki [et al.] // Fetal Diagn.
Ther. - 2012. - Т. 31 - № 4- с.237-43.74.De Jong A. Non-invasive prenatal diagnosis for aneuploidy: toward anintegral ethical assessment. / A. De Jong, W.J. Dondorp, S.G. Frints [et al.] / Hum.Reprod. - 2011. - T. 26 - № 11- с.2915-7.75.Wang E. Gestational age and maternal weight effects on fetal cell-freeDNA in maternal plasma.
/ E. Wang, A. Batey, C. Struble [et al.] // Prenat. Diagn.- 2013. - Т. 33 - № 7- с.662-6.76.Haghiac M. Increased death of adipose cells, a path to release cell-freeDNA into systemic circulation of obese women. / M. Haghiac, N.L. Vora, S. Basu[et al.] // Obesity (Silver Spring) - 2012. - T.20 - №11- с.2213-9.77.Schlütter J.M. The cell-free fetal DNA fraction in maternal blooddecreases after physical activity. / J. M.
Schlütter, L. Hatt, C. Bach [et al.] //Prenat. Diagn. - 2014. - Т. 34 - № 4- 341- с.4.78.Nicolaides K.H. Noninvasive prenatal testing for fetal trisomies in aroutinely screened first-trimester population. / K.H. Nicolaides, А. Syngelaki,G. Ashoor [et al.] // Am. J. Obstet. Gynecol. - 2012. - T.207 - № 5- с.374-e1-6.79.Hall, A.
Non-invasive prenatal diagnosis using cell-free fetal DNAtechnology: applications and implications / A. Hall, A. Bostanci, C.F. Wright //Public Health Genomics. - 2010. - Vol. 13, № 4 – с.246-255.80.Costa, J. M. New strategy for prenatal diagnosis of X-linked disorders128/ J. M. Costa, A. Benachi, E.
Gautier // N. Engl. J. Med. - 2002. - № 346–с.1502.81.Avent, N. D. RHD genotyping from maternal plasma: guidelines andtechnical challenges / N. D. Avent // Methods in Molecular Biology. - 2008. № 444 – с.185-201.82.Fuxi Z. Quantification and application of the placental epigeneticsignature of the RASSF1A gene in maternal plasma / Z. Fuxi, L. Runhua, Y. Jing[et. al.] // Prenat. Diagn.
- 2010. - № 30 – с.778-782.83.Nygren A.O. Quantification of Fetal DNA by Use of Methylation-Based DNA Discrimination / A. O. Nygren, J. Dean, T. J. Jensen [et al.] // Clin.Chem. - 2010. - Vol. 56. – с.1627 - 1635.84.Zamanpoor M. Quantitative analysis of fetal DNA in maternal plasmain gestational diabetes mellitus, iron deficiency anemia and gestationalhypertension pregnancies / M. Zamanpoor, R. Rosli, M. N. Yazid [ et al.] // J.Matern. Fetal. Neonatal.
Med. - 2013. - № 26- с.960-966.85.Tautz D. Hypervariability of simple sequences as a general source forpolymorphic DNA markers. / D. Tautz // Nucleic. Acids. Res. - 1989. - T.17 № 16 –с.6463-71.86.Alford R. L. Rapid and efficient resolution of parentage byamplification of short tandem repeats. / R.L.
Alford, H.A. Hammond, I.Coto,C.T.Caskey // Am. J. Hum. Genet. - 1994. - T. 55 - № 1- с.190-5.87.Yu S.C.Y. Size-based molecular diagnostics using plasma DNA fornoninvasive prenatal testing. / S. C. Y. Yu, K. C. A. Chan, Y. W. L. Zheng [et al.]// Proc. Natl. Acad. Sci. U. S. A. - 2014. - Т. 111 - № 23- с.8583-8.88.Fan H.C.
Detection of aneuploidy with digital polymerase chainreaction / H. C. Fan, S. R. Quake // Anal. Chem. - 2007. - Т. 79 - № 19- с.75767579.89.Ребриков Д.В. NGS: высокопроизводительное секвенирование /Д.В. Ребриков, Д.О. Коростин, Е.С. Шубина, В.В. Ильинский. – М: БИНОМ,2014. – 232 с.90.Fan H.C. Noninvasive diagnosis of fetal aneuploidy by shotgun129sequencing DNA from maternal blood. / H. C.
Fan, Y. J. Blumenfeld, U. Chitkara[et al.] // Proc. Natl. Acad. Sci. U. S. A. - 2008. - Т. 105 - № 42- с.16266-16271.91.Sun K. Size-tagged preferred ends in maternal plasma DNA shed lighton the production mechanism and show utility in noninvasive prenatal testing. /K. Sun, P. Jiang, A.I.C. Wong [et al.] // Proc. Natl. Acad. Sci. U. S. A. - 2018. T.115 - №22 – с.e5106-e5114.92.Yu S.C.
Combined Count- and Size-Based Analysis of MaternalPlasma DNA for Noninvasive Prenatal Detection of Fetal SubchromosomalAberrations Facilitates Elucidation of the Fetal and/or Maternal Origin of theAberrations. / S.C. Yu, P. Jiang, K.C. Chan [et al.] // Clin. Chem. - 2017. - T.63№2 – с.495-502.93.Burton G.J. Optimising sample collection for placental research. /G.J.Burton, N.J. Sebire, L. Myatt [et al.] // Placenta - 2014. - T.35 - № 1 - 9-22.94.Shendure J. Next-generation DNA sequencing. / J. Shendure, H. Ji //Nat.
Biotechnol. – 2008. – Т. 26 – № 10 – с.1135–45.95.Chiu R.W.K. Noninvasive prenatal diagnosis of fetal chromosomalaneuploidy by massively parallel genomic sequencing of DNA in maternal plasma./ R. W. K. Chiu, K. C. A. Chan, Y. Gao [et al.] // Proc. Natl. Acad. Sci. U. S. A. –2008. – Т. 105 – № 51– с.20458–20463.96.Yuan Y. Feasibility study of semiconductor sequencing fornoninvasive prenatal detection of fetal aneuploidy. / Y. Yuan, F.
Jiang, S. Hua [etal.] // Clin. Chem. – 2013. – Т. 59 – № 5– с.846–9.97.Liao C. Noninvasive prenatal diagnosis of common aneuploidies bysemiconductor sequencing. / C. Liao, A. Yin, C. Peng [et al.] // Proc. Natl. Acad.Sci. U. S. A. - 2014.- Т. 111 - № 20 – с.7415- 20.98.Vermeesch J.R. Prenatal and pre-implantation genetic diagnosis. /J.R. Vermeesch, T. Voet, K. Devriendt // Nat. Rev. Genet. - 2016. - T.10 №17 –с.643-56.99.Sparks A.B. Selective analysis of cell-free DNA in maternal blood forevaluation of fetal trisomy. / A.
B. Sparks, E. T. Wang, C. a Struble [et al.] //130Prenat. Diagn. – 2012. – Т. 32 – № 1– с.3–9.100. Sparks A.B. Noninvasive prenatal detection and selective analysis ofcell- free DNA obtained from maternal blood: evaluation for trisomy 21 andtrisomy 18. / A. B. Sparks, C. a Struble, E. T. Wang [et al.] // Am. J. Obstet.Gynecol. – 2012. – Т. 206 – № 4– с.319.e1-9.101. Juneau K. Microarray-Based Cell-Free DNA Analysis ImprovesNoninvasive Prenatal Testing. / K. Juneau, P. E. Bogard, S.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
